---
schema_version: "secwatch.filing_event.v1"
accession: "0000885725-25-000052"
form_type: "8-K"
ticker: "BSX"
cik: "0000885725"
company_name: "BOSTON SCIENTIFIC CORP"
filed_at: "2025-11-19T23:59:59+00:00"
generated_at: "2026-05-16T18:39:33.414331+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Boston Scientific approves 2026 annual bonus and performance share programs with similar structure to 2025

## Summary
- 2026 Annual Bonus Plan approved; bonus pool 0%-150% of target based on global sales, adjusted EPS, operating income, and sustainability goals.
- 2026 rTSR PSP measures TSR vs S&P 500 Healthcare Index over 3 years (2026-2028); awards 0%-200% of target.
- 2026 Organic Net Sales PSP measures organic net sales growth vs financial plan over 3 years; awards 0%-200% of target.
- Both performance programs forfeit if retirement before Jan 1, 2027; all awards subject to clawback policies.

## SEC filing metadata
- accession: 0000885725-25-000052
- form_type: 8-K
- ticker: BSX
- cik: 0000885725
- company_name: BOSTON SCIENTIFIC CORP
- filed_at: 2025-11-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/885725/000088572525000052/0000885725-25-000052-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/885725/000088572525000052/bsx-20251118.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000885725-25-000052
- JSON: https://secwatch.observer/filing/0000885725-25-000052.json
- Plain text: https://secwatch.observer/filing/0000885725-25-000052.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.